Category: NASDAQ:AVXS

Novartis’ $4 Million Gene Therapy — Real Price Or A Negotiation Ploy?

We are in a wondrous age of medicine where CURES for certain types of cancer, rare diseases, blindness and other scourges are imminent. We now need to figure out how to pay for them.